Previously, Zaghri et al. developed novel 4-(imidazolylmethyl)quinoline derivatives 9a–e (Figure 3) that proved to be useful as anti-BC agents against MCF-7 cells; moreover, they exhibited selective cyclooxygenase-2 (COX-2) inhibitory activity. The gene discussed is PTGS2; the disease is breast cancer.